Clinical Trial Update: Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug Indinavir [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating indinavir for classical non-HIV-related Kaposi's sarcoma. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• Indinavir (indinavir)

Snippet

Sponsor: Istituto Superiore di Sanità | Conditions: Classical Kaposi's Sarcoma | Phase 2 | Status: COMPLETED